HLI
Houlihan Lokey, Inc. Financials Investment Advice Russell 3000
$138.00Close
$122.74 – $195.8752-week range
Late-januaryNext report · estimated
Highlights
Strengths
- Accumulation up-day volume 1.5× down-day volume over 50 sessions
Cautions
- Not in an uptrend 1 of 8 trend conditions
- Lagging the market RS 32 · weaker than 68% of stocks over 12 months
- Far from its high 30% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
30%
1wk
up 5.1%
price change
1mo
up 9.2%
price change
12-month return
down 30%
market up 11% ·
its own down 40%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 10%
year on year
EPS growth
up 1%
latest quarter · +19 pts
Sales growth
up 5%
latest quarter · +20 pts
ROE
up 19%
return on equity
Free cash margin
—
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
3.2%
$4.44 a day · 2×ATR $129.12
RS
32 / 99
vs the universe
Trend
1 / 8
trend template
Relative volume
1.0×
vs 50-day average
Up/down volume
1.53
50 sessions
Implied move
—
no scheduled report
Trend template · 1 of 8
- Price above the 50-day average: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Oct 28, 2026
Results reaction
Oct 28, 2026+5% vs market2 sessions after results
Financials
- Gross
- Net 16%
- Cash
- Long-term debt
| FY2021Mar 31, 2021 | FY2022Mar 31, 2022 | FY2023Mar 31, 2023 | FY2024Mar 31, 2024 | FY2025Mar 31, 2025 | FY2026Mar 31, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.3B | $1.8B | $1.9B | $2.4B | $2.6B |
| Gross margin | 34% | 35% | 31% | 30% | 32% | — |
| Operating income | $408.2M | $612.9M | $341.7M | $373.2M | $502.6M | $527.0M |
| Net income | $312.8M | $438.0M | $254.0M | $280.0M | $400.0M | $424.0M |
| Net margin | 21% | 19% | 14% | 15% | 17% | 16% |
| Earnings per share | $4.55 | $6.42 | $3.76 | $4.11 | $5.83 | $6.20 |
| Cash | $846.9M | $833.7M | $714.4M | $721.2M | $971.0M | $1.2B |
| Long-term debt | $55.9M | — | — | — | — | — |
| Shareholders' equity | $1.4B | $1.4B | $1.6B | $1.8B | $2.2B | $2.3B |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 30, 2026 | Quarterly ↗ | Sep 30, 2026 | 30d |
| Jul 31, 2026 | Quarterly ↗ | Jun 30, 2026 | 31d |
| May 22, 2026 | Annual ↗ | Mar 31, 2026 | 52d |
| Feb 3, 2026 | Quarterly ↗ | Dec 31, 2025 | 34d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 15, 2025 | Annual ↗ | Mar 31, 2025 | 45d |
| Feb 4, 2025 | Quarterly ↗ | Dec 31, 2024 | 35d |
| Nov 5, 2024 | Quarterly ↗ | Sep 30, 2024 | 36d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 21, 2024 | Annual ↗ | Mar 31, 2024 | 51d |
| Feb 8, 2024 | Quarterly ↗ | Dec 31, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 28, 2026 | Results ↗ |
| Oct 5, 2026 | Director or officer change ↗ |
| Sep 22, 2026 | Director or officer change · Shareholder vote · Regulation FD ↗ |
| Sep 8, 2026 | Director or officer change ↗ |
| Aug 13, 2026 | Other events ↗ |
| Jul 30, 2026 | Results ↗ |
| May 7, 2026 | Results ↗ |
| Feb 25, 2026 | Other events ↗ |
| Jan 29, 2026 | Results ↗ |
| Jan 29, 2026 | Director or officer change ↗ |
| Dec 30, 2025 | Material agreement ↗ |
| Oct 31, 2025 | Results ↗ |